Avalon GloboCare shares are trading higher after the company announced the USPTO issued a notice of publication for a US patent titled 'QTY Fc Fusion Water Soluble Receptor Proteins'
Portfolio Pulse from Benzinga Newsdesk
Avalon GloboCare's shares are trading higher following the announcement that the USPTO has issued a notice of publication for a US patent titled 'QTY Fc Fusion Water Soluble Receptor Proteins'.
September 05, 2023 | 5:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Avalon GloboCare's stock price is likely to increase in the short term due to the announcement of the USPTO issuing a notice of publication for a US patent.
The announcement of the USPTO issuing a notice of publication for a US patent is a positive development for Avalon GloboCare. This could potentially lead to increased investor confidence and a rise in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100